Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | -66.18%193.26M | 34.49%571.49M | 149.44%424.94M | -859.56M |
| Net profit before non-cash adjustment | -259.24%-224.33M | 25.54%140.87M | -55.25%112.22M | --250.76M |
| Total adjustment of non-cash items | 21.30%465.19M | 38.50%383.52M | 120.74%276.91M | ---1.34B |
| -Depreciation and amortization | 6.48%267.34M | 13.94%251.08M | -8.64%220.36M | --241.21M |
| -Reversal of impairment losses recognized in profit and loss | 79.58%140.94M | 111.55%78.48M | -73.67%37.1M | --140.88M |
| -Disposal profit | ---- | --0 | ---10.23M | --0 |
| -Other non-cash items | 5.49%56.91M | 81.78%53.95M | 101.73%29.68M | ---1.72B |
| Changes in working capital | -201.09%-47.61M | 31.51%47.09M | -84.06%35.81M | --224.69M |
| -Change in receivables | -42.32%-62.43M | 46.67%-43.86M | -9.76%-82.24M | ---74.93M |
| -Change in payables | 20.72%94.72M | -21.08%78.46M | -53.87%99.41M | --215.51M |
| -Provision for loans, leases and other losses | -45.65%50K | -36.11%92K | 305.71%144K | ---70K |
| -Changes in other current assets | -463.76%-42.58M | -198.40%-7.55M | 877.71%7.68M | ---987K |
| -Changes in other current liabilities | -287.21%-37.36M | 84.45%19.96M | -87.30%10.82M | --85.17M |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | ||||
| Interest paid (cash flow from operating activities) | -82.76%-34.51M | -4.50%-18.88M | -5.74%-18.07M | -17.09M |
| Interest received (cash flow from operating activities) | ||||
| Tax refund paid | 87.23%-3.37M | -227.95%-26.37M | -251.61%-8.04M | 5.3M |
| Other operating cash inflow (outflow) | 152.29%27.21M | -87.23%10.79M | -95.83%84.47M | 2.03B |
| Operating cash flow | -66.00%182.59M | 11.12%537.02M | -58.11%483.3M | --1.15B |
| Investing cash flow | ||||
| Net PPE purchase and sale | -53.68%-478.01M | -16.89%-311.04M | -213.19%-266.09M | ---84.96M |
| Net intangibles purchase and sale | ---15.69M | --0 | ---- | ---1.28M |
| Net business purchase and sale | ---- | --0 | --3.28M | --0 |
| Net investment product transactions | 0.00%-60.79M | -98.56%-60.79M | ---30.62M | --0 |
| Net changes in other investments | -152.04%-116.12M | 3.00%-46.07M | 90.05%-47.5M | ---477.13M |
| Investing cash flow | -60.47%-670.61M | -22.58%-417.9M | 39.49%-340.92M | ---563.37M |
| Financing cash flow | ||||
| Net issuance payments of debt | 34.63%384.84M | 199.10%285.85M | -50.43%-288.45M | ---191.75M |
| Net common stock issuance | ---- | -99.73%638K | 395.98%235.96M | --47.58M |
| Net other fund-raising expenses | -78.65%-28.72M | -2,026.59%-16.08M | -118.27%-756K | --4.14M |
| Financing cash flow | 32.01%356.12M | 606.72%269.77M | 61.98%-53.24M | ---140.04M |
| Net cash flow | ||||
| Beginning cash position | 35.94%1.47B | 8.98%1.08B | 83.00%993.04M | --542.66M |
| Current changes in cash | -133.92%-131.9M | 336.29%388.89M | -80.21%89.14M | --450.38M |
| Cash adjustments other than cash changes | ---- | 150.00%1K | ---2K | ---- |
| End cash Position | -8.97%1.34B | 35.94%1.47B | 8.98%1.08B | --993.04M |
| Free cash flow | -247.93%-334.29M | 16.82%225.98M | -81.71%193.45M | --1.06B |
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |